Analyst consensus rating

Eton Pharmaceuticals Analyst Rating: Strong Buy

Direct answer

Eton Pharmaceuticals's consensus rating is Strong Buy.

4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $80.75.
Forecast evidence checked November 21, 2026.

Get free Eton Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$60.85
Average price target
$80.75
High price target
$82.00
Low price target
$80.00
Low target gap
+31.5%
Target upside
+32.7%
High target gap
+34.8%
Target range width
3.3%
Consensus rating
Strong Buy
Analysts
4
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Eton Pharmaceuticals?

Eton Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $80.75.

How far are Eton Pharmaceuticals's low and high targets from the recorded price?

The low target implies +31.5%, while the high target implies +34.8%.

How many analysts are included in Eton Pharmaceuticals's consensus?

The verified consensus includes 4 analysts.

How is Eton Pharmaceuticals's target upside or downside calculated?

The average target of $80.75 is divided by the recorded price of $60.85, then one is subtracted to produce +32.7%. This does not guarantee a future return.

When was Eton Pharmaceuticals's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.